2022年
new order | old order
RevolKa has been selected as a member of the Google for Startups Cloud Program.
RevolKa has been selected as a member of the Google for Startups Cloud Program.
Presenting at Antibody Engineering & Therapeutics
Presenting at Antibody Engineering & Therapeutics
New Tokyo lab has been opened.
Our advertisement feature was published in the online version of Nature
Our advertisement feature was published in the online version of Nature
An interview with our CEO Kataoka was published in the LINK-J
Started a joint research collaboration with Tokyo Medical and Dental University
LATEST ARTICLE
ARCHIVE
- 2023/11 (1)
- 2023/10 (2)
- 2023/09 (2)
- 2023/08 (2)
- 2023/06 (3)
- 2023/05 (1)
- 2023/04 (3)
- 2023/02 (6)
- 2023/01 (2)
- 2022/12 (1)
- 2022/11 (5)
- 2022/10 (5)
CATEGORY
View allTAG